hematopoietic stem cell transplantation (29)
graft vs host disease (10)
multiple myeloma (8)
transplantation conditioning (8)
antineoplastic combined chemotherapy protocols (7)
hodgkin disease (6)
lymphoma (6)
lymphoma, non-hodgkin (5)
hematologic neoplasms (4)
hematopoietic stem cell mobilization (3)
peripheral blood stem cell transplantation (3)
transplantation, autologous (3)
antibodies, monoclonal, humanized (2)
antilymphocyte serum (2)
antineoplastic agents (2)
colorectal neoplasms (2)
cyclophosphamide (2)
elotuzumab (2)
heterocyclic compounds (2)
leukemia, myeloid, acute (2)
lymphoma, b-cell (2)
lymphoma, follicular (2)
siblings (2)
slamf7 (2)
transplantation, homologous (2)
unrelated donors (2)
antibodies, monoclonal (1)
antigens, cd34 (1)
antimetabolites, antineoplastic (1)
antineoplastic agents, immunological (1)
antiviral agents (1)
atorvastatin (1)
bendamustine hydrochloride (1)
blood transfusion (1)
bone marrow cells (1)
brentuximab vedotin (1)
bridged bicyclo compounds, heterocyclic (1)
cd4-positive t-lymphocytes (1)
cd8-positive t-lymphocytes (1)
chemotherapy, cancer (1)
chickenpox (1)
chimerism (1)
clofarabine (1)
clostridioides difficile (1)
clostridium infections (1)
cord blood stem cell transplantation (1)
delayed-action preparations (1)
fluorodeoxyglucose f18 (1)
graft survival (1)
granulocyte colony-stimulating factor (1)